These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15240533)

  • 1. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
    Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
    Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
    Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
    Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
    Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.
    Kim JH; Herlyn D; Wong KK; Park DC; Schorge JO; Lu KH; Skates SJ; Cramer DW; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Oct; 9(13):4782-91. PubMed ID: 14581349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours.
    Zhu Y; Brännström M; Janson PO; Sundfeldt K
    Int J Cancer; 2006 Apr; 118(8):1884-91. PubMed ID: 16287068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
    Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
    Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer.
    Quan J; Yahata T; Adachi S; Yoshihara K; Tanaka K
    Int J Mol Sci; 2011 Jan; 12(2):971-82. PubMed ID: 21541037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants.
    Aravindakshan J; Chen X; Sairam MR
    Neoplasia; 2006 Dec; 8(12):984-94. PubMed ID: 17217615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
    Litkouhi B; Litkouhi B; Fleming E; Welch WR; Berkowitz RS; Birrer MJ; Mok SC
    Gynecol Oncol; 2008 May; 109(2):234-9. PubMed ID: 18331757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration.
    Fan Q; Cheng JC; Qiu X; Chang HM; Leung PC
    Biochem Biophys Res Commun; 2015 Feb; 457(3):256-61. PubMed ID: 25576358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-7 expression in human epithelial ovarian cancer.
    Tassi RA; Bignotti E; Falchetti M; Ravanini M; Calza S; Ravaggi A; Bandiera E; Facchetti F; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2008; 18(6):1262-71. PubMed ID: 18298564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
    Wang G; Zhang Z; Ren Y
    Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.